GRIN2B and triple-negative breast carcinoma: Among the latter, elevated expression of GRIN2B was significantly associated with triple-negative breast cancer (TNBC) characterized by unfavorable prognosis, lack of expression of hormone receptors (ER and PR), and of the growth factor receptor Her2 [5].